MABTAS INJ

Overview

MABTAS INJ is a Schedule H drug.

MABTAS INJ is composed of: RITUXIMAB (10 MG/ML)

Rituximab is a cancer medicine that interferes with the growth and spread of cancer cells in the body.Rituximab is also used in combination with steroid medicines to treat certain rare disorders that cause inflammation of blood vessels and other tissues in the body.Rituximab is a monoclonal antibody that specifically binds to receptors on cancer cells. Thus it flags the cancer cells for destruction by the body’s immune system.

Usage

RITUXIMAB is generally used to treat: Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Wegener’s Granulomatosis, Microscopic Polyangiitis
RITUXIMAB can address symptoms like: Fever, Night Sweats, Fatigue (tiredness), Weight Loss (unintentional), Loss Of Appetite

Frequently Asked Questions

Q: Is it safe on my liver?
A: Not Safe

Q: Is it safe on my kidney?
A: Not Safe

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Not enough studies to prove Risk – Ask your Doctor

Precautions for MABTAS INJ and its Constituents


  • You should not be treated with rituximab if you are allergic to it.
  • Rituximab is injected into a vein through an IV. A healthcare provider will give you this injection.
  • Rituximab is not given daily. Your schedule will depend on the condition being treated.
  • Before each injection, you may be given other medications to prevent certain side effects of rituximab.
  • While using rituximab, you may need frequent blood tests.
  • If you have ever had hepatitis B, rituximab can cause this condition to come back or get worse. You will need frequent liver function tests during treatment and for several months after you stop using this medicine.
  • Do not receive a "live" vaccine while using rituximab, and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to youIt may cause dizziness, do not drive a car or operate machinery while taking this medication.
  • Use rituximab with extreme caution in children and elderly.
  • You may be asked to stop taking medicines for high blood pressure 12 hours before you receive rituximab as it may cause a fall in the blood pressure.
  • Avoid activities that may cause bruising or injury as rituximab may reduce the number of clot-forming cells (platelets) in your blood.

Symptoms of Overdosage

RITUXIMAB over-dosage can result in: Difficulty Breathing

Common Side-Effects

RITUXIMAB : Neutropenia, Edema, Joint Pain, Diarrhoea, Muscle Pain, Muscle Cramp, Fever, Chills, Body Pain, Runny Nose, Sneezing, Throat Soreness, Abdomen Bloating Or Fullness, Confusion, Cough, Dizziness, Fainting, Drowsiness, Dry Mouth, Head Headache, Nausea, Nervousness, Pale Skin, Abdomen Pain, Vomit, Mouth Blisters, Decreased Urination, Body Loss Of Movement, Restless Or Irritability, Irregular Heartbeat, Loss Of Appetite, Hands Numbness, Feet Numbness, Eyes Itching, Eyes Redness, Difficulty Concentrating, Difficulty Sleeping, Eyes Dry Eyes, Agitation, Decreased Taste, Lightheadedness, Spinning Sensation, Abdomen Swelling

Serious Side-Effects

RITUXIMAB : Anxiety, Mouth Ulcer, Seizure, Palpitation, Anemia, Cancer, Black (tar) Colored Stools, Gums Bleeding, Eyes Blurred Vision, Blood Or Red Colored Urine, Bloody Or Red Colored Stools, Chest Pain, Difficulty Breathing, Fruity Odor On Breath, Increased Thirst, Frequent Urination, Lower Back Pain, Noisy Breathing, Pain With Urination, Mouth Soreness, Body Excessive Sweating, Hands Tingling, Swollen Tongue, Weight Loss (unintentional), Fearful, Night Sweats

Disease Interactions

RITUXIMAB can interfere with: Lymphoma, Heart Arrhythmias, Hepatitis, Bacterial Infection, Fungal Infection, Acute Renal Failure

Technical Classification

RITUXIMAB is categorized as:
  • ANTIRHEUMATICS / MISCELLANEOUS AGENTS
  • CD20 MONOCLONAL ANTIBODIES / ANTINEOPLASTICS

Available Alternatives for MABTAS INJ

What are the commonly available Substitutes?

MABTAS INJINR 6900 for 10 ML INJECTIONRITUXIMAB 10 MG/ML
REDITUX INJINR 9999 for 10 ML INJECTIONRITUXIMAB 10 MG/ML
REDITUX-RA INJINR 79992 for 2 INJRITUXIMAB 10 MG/ML

What are the other drugs with similar Ingredients?

CYTOMAB 500MG INJINR 31250 for 1 ML INJECTIONRITUXIMAB 500.0 MG
IKGDAR 100MG INJINR 7142.86 for 1 INJECTIONRITUXIMAB 100.0 MG
IKGDAR 500MG INJINR 35714.3 for 1 INJECTIONRITUXIMAB 500.0 MG
LUPIXIMAB 100MG INJINR 8500 for 1 INJECTIONRITUXIMAB 100.0 MG
MABALL 100MG INJINR 5000 for 10 ML INJECTIONRITUXIMAB 100.0 MG
MABALL 500MG INJINR 25000 for 50 ML INJECTIONRITUXIMAB 500.0 MG
MABTAS 10MG INFUSIONINR 5139.28 for 10 ML INFUSIONRITUXIMAB 10.0 MG
MABTAS 500MG INFUSIONINR 25278.6 for 50 ML INFUSIONRITUXIMAB 500.0 MG
MABTAS N 100MG INJINR 7109 for 10 ML INJECTIONRITUXIMAB 100.0 MG
MABTAS N 500MG INJINR 37500 for 50 ML INJECTIONRITUXIMAB 500.0 MG
MABTAS RA 500MG INJINR 37500 for 50 ML INJECTIONRITUXIMAB 500.0 MG
MABTAS T 100MG INJINR 7142.86 for 10 ML INJECTIONRITUXIMAB 100.0 MG
MABTAS T 500MG INJINR 44642.9 for 50 ML INJECTIONRITUXIMAB 500.0 MG
REDITUX 100MG INJINR 9999 for 10 ML INJECTIONRITUXIMAB 100.0 MG
REDITUX 500MG INJINR 39996 for 50 ML INJECTIONRITUXIMAB 500.0 MG
REDITUX RA 500MG INFUSIONINR 76182.9 for 50 ML INFUSIONRITUXIMAB 500.0 MG
RISTOVA 100MG INJINR 7568.75 for 1 INJECTIONRITUXIMAB 100.0 MG
RISTOVA 500MG INJINR 37500 for 1 INJECTIONRITUXIMAB 500.0 MG
RITUXIMABRITUXIMAB
RITUXIREL 100MG INJINR 9945 for 100 MG INJECTIONRITUXIMAB 100.0 MG
RITUXIREL 500MG INJINR 39957 for 50 ML INJECTIONRITUXIMAB 500.0 MG
TORITZ 100MG INJINR 9466.25 for 1 INJECTIONRITUXIMAB 100.0 MG